Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

DS Healthcare Group Inc prepares to file investigational new drug application with FDA

Thursday, 9 Jan 2014 08:00am EST 

DS Healthcare Group Inc:Says it is preparing to submit to the United States Food and Drug Administration (FDA) an Investigational New Drug Application (IND) for its topical hair loss treatment. 

Company Quote

0.05 +3.31%
9 Jul 2014